A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PDDS

Search Conditions:
Search Keyword : PDDS
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PDDS
Appearance Frequency: 98 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
Patient Determined Disease Steps
(71 times)
Neurology
(24 times)
MS (55 times)
NARCOMS (15 times)
EDSS (10 times)
2005 Validation of the NARCOMS Registry: pain assessment.
Pulmonary Drug Delivery System
(6 times)
Drug Therapy
(3 times)
AEs (1 time)
ARF (1 time)
CKD (1 time)
2007 Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients.
Parkinson's Disease Disability Scale
(3 times)
Parkinson Disease
(1 time)
UPDRS (3 times)
BBS (2 times)
MIRT (2 times)
2012 Rehabilitation improves dyskinesias in Parkinsonian patients: a pilot study comparing two different rehabilitative treatments.
Particulate drug delivery systems
(2 times)
Biomedical Engineering
(1 time)
ADDS (1 time)
AMS (1 time)
MC (1 time)
2015 Antibody-based molecular communication for targeted drug delivery systems.
Pulsatile drug delivery system
(2 times)
Biocompatible Materials
(1 time)
--- 2011 Recent technologies in pulsatile drug delivery systems.
disability-Patient Determined Disease Steps
(1 time)
Multiple Sclerosis
(1 time)
CUs (1 time)
MS (1 time)
NUs (1 time)
2018 Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
pain, walking, depression, fatigue, and global disability
(1 time)
Nervous System Diseases
(1 time)
AA (1 time)
HA (1 time)
MS (1 time)
2021 How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity.
Parent Diabetes Distress Scale
(1 time)
Pediatrics
(1 time)
DD (1 time)
EFA (1 time)
2016 Understanding the Areas and Correlates of Diabetes-Related Distress in Parents of Teens With Type 1 Diabetes.
PD Disability Scale
(1 time)
Neurology
(1 time)
6MWT (1 time)
MIRT (1 time)
PD (1 time)
2014 Intensive rehabilitation treatment in early Parkinson's disease: a randomized pilot study with a 2-year follow-up.
10  PDDS/BR
(1 time)
Multiple Sclerosis
(1 time)
EDSS (1 time)
MS (1 time)
SDMT (1 time)
2019 Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.
11  Perceived Devaluation and Discrimination Scale
(1 time)
Psychiatry
(1 time)
DACC-MH (1 time)
RIBS (1 time)
2021 Stigma Towards Mental Illness at an Academic Tertiary Care Center in Lebanon.
12  perceived discrimination and devaluation scale
(1 time)
Psychiatry
(1 time)
--- 2016 Influence of urbanity on perception of mental illness stigma: a population based study in urban and rural Hanoi, Vietnam.
13  Personalized drug delivery systems
(1 time)
Drug Therapy
(1 time)
PSC (1 time)
2021 Integration of personalized drug delivery systems into digital health.
14  photo-dependent denitryfying sludge
(1 time)
Environmental Health
(1 time)
--- 2002 Continuous treatment of azo acid dyes by photo-dependent denitrifying sludge.
15  picoliter droplet dispensing system
(1 time)
Chemistry
(1 time)
--- 2019 On the Droplet Size and Application of Wettability Analysis for the Development of Ink and Printing Substrates.
16  postpsychotic depressive disorder of schizophrenia
(1 time)
Psychiatry
(1 time)
MDE (1 time)
PSD (1 time)
2003 Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria.
17  pouch drug delivery systems
(1 time)
Drug Delivery Systems
(1 time)
TM (1 time)
2015 Pouch drug delivery systems for dermal and transdermal administration.
18  propanediamine-N,N'-disuccinic acid
(1 time)
Biochemistry
(1 time)
EDDS (1 time)
EDTA (1 time)
NTA (1 time)
1997 Biodegradabilities of ethylenediamine-N,N'-disuccinic acid (EDDS) and other chelating agents.
19  protein drug delivery system
(1 time)
Biomimetics
(1 time)
AlClPc (1 time)
BBB (1 time)
GBM (1 time)
2020 Design of new protein drug delivery system (PDDS) with photoactive compounds as a potential application in the treatment of glioblastoma brain cancer.